DermTopic: Psoriasis

Filter Your Results

 

News

 

FDA Approves Addition of Moderate to Severe Fingernail Psori…

The FDA approved the inclusion of moderate to severe fingernail psoriasis data in AbbVie's Humira (adalimumab) presc…

DermWireTV: Dupixent, JuvĂ©derm Vollure XC, Bavencio Approva…

The FDA has approved Regeneron’s injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It wi…

DermWire.com

Study: Severe Psoriasis More Common in Men

Severe psoriasis predominantly affects men, according to a new study in the American Journal of Clinical Dermatolog…

Ease On Down The Road: Getting Started with MIPS

No one can blame dermatologists for feeling fatigued at the mere mention of the Medicare Access and CHIP Reauthorization…

Mark Kaufmann, MD

Sandoz Proposed Biosimilar Shows Equivalent Efficacy to Humi…

Sandoz’s proposed biosimilar adalimumab (GP2017) shows equivalent efficacy to reference medicine, according to dat…

Sun Pharma to Present Data from Tildrakizumab Clinical Devel…

Sun Pharmaceutical Industries Ltd will present several new analyses from Phase-1 and the pivotal Phase-3 clinical trials…

AAD Launches SkinSerious Campaign

The American Academy of Dermatology is launching a new campaign to raise awareness of the breadth of serious skin diseas…

Skin Diseases Remain Major Cause of Disability

Skin diseases are the fourth leading cause of disability worldwide, according to the Global Burden of Disease 2013 Study…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.